|
Lagutina S.N., Pashkova A.A., Dudurich V.V., Danilov L.G., Ermachenko E.D.
Diagnostical value of intestinal microbiota as one of the leading factors of the development of ulcerative colitis in type 2 diabetes mellitus patients
|
№3 / 2024
|
|
Yuzhakova E.V., Smirnova E.N.
Experience of dapagliflozin use in elderly female patients with hyperactive urinary bladder
|
№1 / 2024
|
|
Demidova T.Yu., Ushanova F.O.
The role and place of dipeptidyl peptidase-4 inhibitors in modern approaches to the management of type 2 diabetes mellitus
|
№9 / 2023
|
|
Larina V.N., Lankin A.O., Larin V.G., Golovko M.G.
Modern viewpoint at prediabetes: Prevalence, diagnostic criteria, risk groups, screening
|
№9 / 2023
|
|
Demicheva T.P.
Relationship of depressive and eating disorders, quality of life in women with complicated type 2 diabetes mellitus
|
№9 / 2023
|
|
Teplova, A.S. Demidova T.Yu., Lobanova K.G.
Peculiarities of outpatient glycemic profile of patients with type 2 diabetes mellitus during innovative sugar-reducing therapy combined with metformin according to flash glucose monitoring data
|
№9 / 2023
|
|
Demidova T.Yu., Izmaylova M.Ya., Antsiferov M.B.
Possibilities of early diagnosis of chronic heart failure and chronic kidney disease in patients with type 2 diabetes mellitus at the hospital stage
|
№9 / 2023
|
|
Skuridina D.V., Demidova T.Yu.
Clinical and metabolic peculiarities in male patients with type 2 diabetes mellitus and hypogonadism
|
№9 / 2023
|
|
Usanova A.A., Lavrenova E.A., Kunyaeva T.A., Kuzma F., Novikova E.K., Sergutova N.P., Chatkina T.A.
Modern aspects of use of tirzepatide – the first dual agonist of glucagon-like peptide-1 and glucosependent insulinotropic peptide receptors
|
№8 / 2023
|
|
Demidova T.Yu., Titova V.V.
The role of self-monitoring of glycemia in the treatment of patients with type 2 diabetes mellitus and the achievement of the target level of carbohydrate metabolism
|
№5 / 2023
|
|
Semenova T.N., Grigoryeva V.N., Zanozina O.V., Sukhanov S.A.
Cognitive disorders in patients with hypertonic cerebral microangiopathy associated with type 2 diabetes mellitus and COVID-19
|
№5 / 2023
|
|
Panevin T.S., Eliseev M.S., Bobkova A.O., Dimitreva A.E., Urumova M.M.
Use of dapagliflozin in a comorbid patient: new opportunities
|
№3 / 2023
|
Русский
